Trademark: 97010808
Status Date
Monday, September 4, 2023
Filing Date
Friday, September 3, 2021
Published for Opposition
Tuesday, December 6, 2022
Abandoned Date
Monday, September 4, 2023
5 pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Sep 5, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 4, 2023
Abandonment - No Use Statement Filed
Jan 31, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 3, 2022
Approved For Pub - Principal Register
Nov 3, 2022
Teas/Email Correspondence Entered
Nov 2, 2022
Correspondence Received In Law Office
Nov 2, 2022
Teas Response To Office Action Received
May 6, 2022
Notification Of Priority Action E-Mailed
May 6, 2022
Priority Action E-Mailed
May 6, 2022
Priority Action Written
May 3, 2022
Assigned To Examiner
Oct 15, 2021
New Application Office Supplied Data Entered
Sep 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
